UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: May 20, 2015

(Date of earliest event reported: January 12, 2015)

 

UNITED HEALTH PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

814-00717

 

84-1517723

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

10624 S. Eastern Ave., Ste. A209

Henderson, NV 89052

(Address of principal executive offices, zip code)

 

(877) 358-3444

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

 

 

  

Item 1.01. Entry into a Material, Definitive Agreement

 

On January 12, 2015, the Registrant entered into an employment agreement with Douglas Beplate, Chief Executive Officer of the Registrant. The employment agreement was previously filed as Exhibit 10.1.

 

Item 3.02. Unregistered Sale of Equity Securities

 

Reference is made to Douglas Beplate’s employment agreement as to compensation received by him. Mr. Beplate received 9,900,000 common shares valued at $891,000 in exchange for $542,776 indebtedness owed to him, plus a bonus of $348,224.

  

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers.

 

On January 12, 2015, the Registrant entered into an employment agreement with Douglas Beplate, Chief Executive Officer of the Registrant. The employment agreement was previously filed as Exhibit 10.1.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Description
 

 
10.1

 

Employment Agreement dated January 12, 2015 – Douglas Beplate. (Previously filed.)

 

 
2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

UNITED HEALTH PRODUCTS, INC.

 
   

Dated: May 20, 2015

/s/ Douglas Beplate

 
 

Douglas Beplate, Chief Executive Officer

 

 

 

3